Historical shareholding details of iShares Micro-Cap ETF holdings in Design Therapeutics Inc (DSGN)

Monthly changes of iShares Micro-Cap ETF shareholding in Design Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Micro-Cap Etf 70,524 0.12%
Feb 27, 2025 Ishares Micro-Cap Etf 70,524 0.12%
Feb 26, 2025 Ishares Micro-Cap Etf 70,524 0.12%
Jan 31, 2025 Ishares Micro-Cap Etf 72,974 0.13%
Jan 29, 2025 Ishares Micro-Cap Etf 72,974 0.13%
Dec 31, 2024 Ishares Micro-Cap Etf 71,994 0.13%
Dec 30, 2024 Ishares Micro-Cap Etf 71,994 0.13%
Nov 30, 2024 Ishares Micro-Cap Etf 72,881 0.13%
Nov 27, 2024 Ishares Micro-Cap Etf 72,881 0.13%
Oct 31, 2024 Ishares Micro-Cap Etf 72,881 0.13%
Oct 30, 2024 Ishares Micro-Cap Etf 72,881 0.13%
Oct 29, 2024 Ishares Micro-Cap Etf 72,881 0.13%
Sep 30, 2024 Ishares Micro-Cap Etf 71,484 0.13%
Sep 27, 2024 Ishares Micro-Cap Etf 71,484 0.13%
Sep 25, 2024 Ishares Micro-Cap Etf 71,484 0.13%
Aug 30, 2024 Ishares Micro-Cap Etf 73,650 0.13%
Aug 29, 2024 Ishares Micro-Cap Etf 73,650 0.13%
Aug 28, 2024 Ishares Micro-Cap Etf 73,650 0.13%
Jul 31, 2024 Ishares Micro-Cap Etf 72,648 0.13%
Jul 29, 2024 Ishares Micro-Cap Etf 72,648 0.13%
Jun 28, 2024 Ishares Micro-Cap Etf 68,170 0.12%
Jun 13, 2024 Ishares Micro-Cap Etf 68,657 0.12%
May 29, 2024 Ishares Micro-Cap Etf 71,092 0.13%
Apr 26, 2024 Ishares Micro-Cap Etf 70,414 0.12%
Mar 28, 2024 Ishares Micro-Cap Etf 71,833 0.13%
Mar 26, 2024 Ishares Micro-Cap Etf 71,833 0.13%
Feb 29, 2024 - - 0.13%
Feb 28, 2024 Ishares Micro-Cap Etf 72,779 0.13%
Jan 29, 2024 Ishares Micro-Cap Etf 73,725 0.13%
Dec 27, 2023 Ishares Micro-Cap Etf 73,725 0.13%
Nov 29, 2023 Ishares Micro-Cap Etf 73,224 0.13%
Oct 31, 2023 Ishares Micro-Cap Etf 72,752 0.13%
Sep 27, 2023 Ishares Micro-Cap Etf 71,104 0.13%
Aug 29, 2023 Ishares Micro-Cap Etf 74,849 0.13%
Jul 28, 2023 Ishares Micro-Cap Etf 74,543 0.13%
Jun 21, 2023 Ishares Micro-Cap Etf 73,774 0.13%
May 30, 2023 Ishares Micro-Cap Etf 73,041 0.13%

View all ownership details of Design Therapeutics Inc